We found that both ENT1 and ENT2 were primarily localized in inflammatory cells of lung tissues from COVID-19 patients (Figure 4; Table 2), making them potentially liable to SARS-CoV-2-mediated increases in expression. Here, SLC29A1 is linked to COVID-19.